bill curtis

William W. Curtis

Chief Executive Officer

William Curtis is Chief Executive Officer of nRichDX and a member of its Board of Directors. William joined nRichDX in July 2015 and brings over 30 years of experience in the healthcare industry. He has exclusively been involved in healthcare business development and healthcare services since 1983.

Prior to joining nRichDX, William was the co-founder, Chairman and Chief Executive Officer of CBLPath Holdings Corporation, a specialized anatomic pathology and molecular laboratory that under his leadership experienced organic, profitable revenue growth from $4MM to $85+MM. Previously, he was the founder and Chief Executive Officer of MLC International and The Hillside Group, healthcare financial and business development companies.

(949) 484-9293 phone

Nafiseh Jafari

Nafiseh Jafari, PhD

Director of Research and Development

Nafiseh Jafari, PhD is Director of Research and Development at nRichDX. Nafiseh
joined nRichDX in January 2020 and has over 10 years experience in life science
research. She is a scientific leader with a passion for building and managing high
performance teams. Nafiseh has managed multimillion dollar development projects
leading to the successful creation and launch of multiple products. Her expertise
in talent management and quality/design control systems make her a key member of
the nRichDX team.
Immediately prior to joining nRichDX, Nafiseh was a Project Manager leading cross
functional teams at Abbott Diagnostics. She holds a B.S. degree in Chemistry from
Sharif University of Technology and earned her Ph.D. degree in Biochemistry and
Molecular Biology at Western Michigan University.

Mayer Saidian

Mayer Saidian, PhD

Director of Application Development

Mayer Saidian, PhD is Director of Application Development for nRichDX.
Mayer joined nRichDX in early 2020 and brings over 15 years of
development experience in molecular biology and life sciences. Mayer is a
scientific leader with passion for breakthrough technologies and combining
cutting edge technologies and bringing them into the scientific and clinical
Prior to joining nRichDX, Mayer was conducting multi-disciplinary and
international research at University of California, Irvine and Hebrew
University in Jerusalem to develop no-invasive methodologies to diagnose
internal diseases, such as diabetes, through the skin. Mayer used advanced
technologies and machine learning skills to perform this study.
Mayer holds B.S. and M.S. degrees in biology and chemistry and earned his
Ph.D. degree in Pharmacology at the Hebrew University in Jerusalem and
University of California, Irvine.

steve blanc

Steve Blanc

Chief Commercial Officer

Steve Blanc is a strategic and tactical expert in leading sales teams and driving company growth. He has a proven track record producing revenue streams and operational enhancements in multiple sales, marketing and general management roles both domestic and international. His experience spans capital equipment, service and consumables sales to a broad range of customers: hospitals, government research institutes, reference labs, pharmaceutical and biotech companies.

Throughout a successful three-decade plus tenure, Steve consistently achieved unprecedented results in multiple sales, marketing and general management roles while successfully leading both domestic and international sales teams. He progressed to the highest level of executive sales responsibility within the multi billion-dollar life sciences diagnostic company, Beckman Coulter.

TC headshot2_web

Tom Curtis

Senior Vice President Of Marketing and Commercial Operations

Tom Curtis is a life sciences marketing and commercial leader with over 20 years of experience in genomics, biotechnology tools, clinical and molecular diagnostics at industry leaders and start-ups including Human Genome Sciences, OriGene Technologies, QIAGEN, CBLPath, and Sonic Healthcare. He has built successful brands and launched numerous category-leading products, including QIAGEN’s EZ1® and QIAsymphony® nucleic acid extraction platforms, and CBLPath’s ThyroSeq® Thyroid Genomic Classifier. Skilled at building teams and leading people, he excels at strategic and tactical marketing, sales enablement, and commercial operations. Tom has a B.S. degree in Biochemistry from Virginia Tech and graduate education in Marketing from Harvard’s Extension School (HES).


David W. Parker

Chief Financial Officer

David Parker has over 30 years of accounting, finance and business management experience. Prior to nRichDX, he served as contract CFO for a for an R&D start-up biotechnology company where he was responsible for completing the initial corporate organization as well as the setup of all accounting and reporting functions.

From 2003 through 2014, he was Senior Vice President and Chief Financial Officer of CBLPath Holdings Corporation. CBLPath is a leading provider of sub-specialized anatomic pathology and molecular diagnostic laboratory services. Annual revenues for CBLPath grew from $4MM in 2003 to over $85MM in 2010 when CBLPath was acquired by Sonic HealthCare USA.

Previously, he served as the Vice President of Finance and Administration for The Hillside Group, Vice President of Business Operations for RMS Communications Group, Inc., Vice President and Chief Financial Officer for MFM Industries, Inc., Senior Vice President, Chief Financial Officer and Secretary for Mid-State Federal Savings Bank, and auditor for Deloitte & Touche USA, LLP.

David holds a B.A. in Accounting and Finance from the University of West Florida.

tim bruemmer

Tim Bruemmer

Director of Engineering

Tim Bruemmer is a serial entrepreneur who has also experienced extensive success in large public companies. Tim’s passion is innovation and he has founded numerous high-technology companies in a variety of markets with multiple successful exits. He is also an intrapreneur, having led both a global engineering development organization as well as a global science and engineering research and development organization. In those roles, Tim was responsible for the development and launch of dozens of new products in regulated and research markets leading to > $1B in cumulative revenue and often resulting in market leading positions. In addition, Tim has extensive experience driving value creation through acquisitions, leading technical due-diligence efforts and integrating both acquired product lines and entire businesses into companies he founded and as an executive within a Fortune 500 company. These experiences, plus his experiences creating and managing organizational structures for manufacturing operations, product development and quality systems, provide Tim with an intimate understanding of the impact of corporate structure and culture on innovation. Tim has a B.S. in Chemical Engineering from the University of California at Berkeley, started his career at Eastman Kodak and has spent 35 years building and optimizing innovative organizations. These experiences make Tim uniquely capable in both intrapreneurial and entrepreneurial environments.

Ready to learn more?

Request demo

Keep up to date with nRichDX

You’ll be the first to know about product updates and latest industry news.